CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 113 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $5,746,000 | +18.6% | 1,641,804 | 0.0% | 15.17% | -13.7% |
Q2 2022 | $4,843,000 | -5.2% | 1,641,804 | 0.0% | 17.57% | +12.9% |
Q1 2022 | $5,106,000 | -8.0% | 1,641,804 | 0.0% | 15.56% | +10.8% |
Q4 2021 | $5,549,000 | -7.4% | 1,641,804 | 0.0% | 14.05% | +69.0% |
Q3 2021 | $5,993,000 | -16.3% | 1,641,804 | 0.0% | 8.31% | +9.5% |
Q2 2021 | $7,158,000 | -4.0% | 1,641,804 | 0.0% | 7.59% | +15.9% |
Q1 2021 | $7,454,000 | -20.9% | 1,641,804 | 0.0% | 6.54% | -40.3% |
Q4 2020 | $9,424,000 | -20.7% | 1,641,804 | 0.0% | 10.95% | +23.8% |
Q3 2020 | $11,887,000 | +112.9% | 1,641,804 | +2.6% | 8.85% | +78.3% |
Q2 2020 | $5,584,000 | +89.4% | 1,599,958 | +6.3% | 4.96% | +200.4% |
Q4 2019 | $2,949,000 | -61.8% | 1,504,710 | -0.2% | 1.65% | -43.9% |
Q3 2019 | $7,721,000 | -32.1% | 1,508,091 | -5.0% | 2.95% | -20.9% |
Q2 2019 | $11,364,000 | -46.1% | 1,587,101 | 0.0% | 3.73% | -32.1% |
Q1 2019 | $21,077,000 | +68.8% | 1,587,101 | 0.0% | 5.49% | +33.7% |
Q4 2018 | $12,490,000 | -27.8% | 1,587,101 | +1.6% | 4.10% | +7.4% |
Q3 2018 | $17,307,000 | -17.4% | 1,562,040 | 0.0% | 3.82% | -15.4% |
Q2 2018 | $20,963,000 | +3.3% | 1,562,040 | 0.0% | 4.51% | +2.1% |
Q1 2018 | $20,291,000 | +267.6% | 1,562,040 | +160.3% | 4.42% | +185.5% |
Q4 2017 | $5,520,000 | +14.1% | 600,000 | 0.0% | 1.55% | +16.3% |
Q3 2017 | $4,836,000 | – | 600,000 | – | 1.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lynx1 Capital Management LP | 1,653,495 | $10,367,414 | 8.97% |
Versant Venture Management, LLC | 543,753 | $3,409,330 | 7.06% |
TCG Crossover Management, LLC | 5,905,400 | $37,026,858 | 6.54% |
COMMODORE CAPITAL LP | 5,738,500 | $35,980 | 5.42% |
Foresite Capital Management IV, LLC | 1,787,094 | $11,205,079 | 4.79% |
Saturn V Capital Management LP | 1,611,778 | $5,718,432 | 4.74% |
ACUTA CAPITAL PARTNERS, LLC | 1,015,000 | $6,364,050 | 3.92% |
Altium Capital Management LP | 1,025,000 | $6,426,750 | 3.27% |
Affinity Asset Advisors, LLC | 1,143,531 | $7,169,939 | 2.81% |
GREAT POINT PARTNERS LLC | 1,550,000 | $9,718,500 | 1.90% |